Senda Biosciences Competitors and Similar CompaniesClear all
Senda Biosciences's competitors and similar companies include Mosaic ImmunoEngineering, MaxCyte, TC BioPharm and Bolt Biotherapeutics.
 Senda Biosciences Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes. |  Mosaic ImmunoEngineering Mosaic ImmunoEngineering (formerly known as Patriot Scientific Corporation) is a biotechnology company focused on bridging immunology and engineering to develop immunotherapies to treat and prevent cancer and infectious diseases. |  MaxCyte MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization. |  TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products. |  Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | |
Founding Date | Founding Date 2017 | Founding Date 1987 | Founding Date 1998 | Founding Date 2013 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Carlsbad, US HQ | Locations Gaithersburg, US HQ Alderley Edge, GB | Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB | Locations Redwood City, US HQ |
Employees | Employees 16 | Employees 1 | Employees 65 | Employees 41 | Employees 5248% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 6.5 m | Valuation ($) 387.9 m | Valuation ($) 926.7 k | Valuation ($) 25.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $33m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $6.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $26.8m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($687.8k) (FY, 2025) | Net income ($44.6m) (FY, 2025) | Net income (£12.2m) (FY, 2024) | Net income ($33.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 31.3m | Total funding raised $ 33.2m | Total funding raised $ 177.5m |
For sources of this data, please see the company profile
View Company Profiles
Mosaic ImmunoEngineering
HQ
Carlsbad, US
Employees
1
Mosaic ImmunoEngineering (formerly known as Patriot Scientific Corporation) is a biotechnology company focused on bridging immunology and engineering to develop immunotherapies to treat and prevent cancer and infectious diseases.
View companyMaxCyte
HQ
Gaithersburg, US
Employees
65
MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization.
View companyTC BioPharm
HQ
Holytown, GB
Employees
41
TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.
View companyBolt Biotherapeutics
HQ
Redwood City, US
Employees
52↓ 48% decrease
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
View company